Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.52 |
| ▸ | P2RY14 | Q15391 | 1/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.51 |
| ▸ | ACE | P12821 | 3/20 | 0.51 |
| ▸ | MEN1 | O00255 | 4/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | POLB | P06746 | 2/20 | 0.50 |
| ▸ | IDO1 | P14902 | 1/20 | 0.50 |
| ▸ | ITGB2 | P05107 | 1/20 | 0.50 |
| ▸ | ICAM1 | P05362 | 1/20 | 0.50 |
| ▸ | ITGAL | P20701 | 1/20 | 0.50 |
| ▸ | P4HB | P07237 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | MPO | P05164 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | BLM | P54132 | 1/20 | 0.50 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.50 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31258750 | 1.00 | ERAP2 (0.52) | ERAP2P2RY14ALOX15ACEMEN1 | |
| SCHEMBL22322144 | 1.00 | ERAP2 (0.52) | ERAP2P2RY14ALOX15ACEMEN1 | |
| SCHEMBL17848778 | 0.91 | ACE (0.54) | ERAP2P2RY14ALOX15ACEMEN1 | |
| SCHEMBL5805740 | 0.91 | ACE (0.54) | ERAP2P2RY14ALOX15ACEMEN1 | |
| SCHEMBL8525238 | 0.88 | MEN1 (0.57) | ERAP2P2RY14ALOX15ACEMEN1 | |
| SCHEMBL5281197 | 0.88 | MEN1 (0.57) | ERAP2P2RY14ALOX15ACEMEN1 | |
| Tryptamine SCHEMBL13278244 | 0.86 | MPO (0.52) | ERAP2P2RY14ALOX15ACEMEN1 | |
| SCHEMBL3344871 | 0.85 | MC4R (0.55) | ERAP2P2RY14ALOX15ACEITGB2 | |
| SCHEMBL7271569 | 0.85 | MC4R (0.55) | ERAP2P2RY14ALOX15ACEITGB2 | |
| SCHEMBL13278205 | 0.84 | ALOX15 (0.70) | ERAP2P2RY14ALOX15ACEMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4017281-A1 | PET FOOD COMPOSITIONS | Hill's Pet Nutrition, Inc. (US) | 2022-06-29 | — | — | EP | claimed |
| WO-2021127701-A1 | PET FOOD COMPOSITIONS | HILL'S PET NUTRITION, INC. (US) | 2021-06-24 | — | — | WO | claimed |
| EP-1052968-B1 | ALPHA-AMIDES OF(L)-AMINO ACIDS AS FRAGRANCE PRECURSORS | GILLETTE CO (US) | 2007-12-05 | — | — | EP | claimed |
| US-5932198-A | α-amides of L-amino acids as fragrance precursors | THE GILLETTE COMPANY (US) | 1999-08-03 | — | — | US | claimed |
| US-20260034086-A1 | Pet Food Compositions Comprising Caprylic Acid And Docosahexaenoic Acid And/Or Eicosapetaenoic Acid For Use In Treating Struvite Urolithiasis | HILL'S PET NUTRITION, INC. (US) | 2026-02-05 | — | — | US | disclosed |
| US-20250380721-A1 | Pet Food Compositions | HILL'S PET NUTRITION, INC. (US) | 2025-12-18 | — | — | US | disclosed |
| US-12458617-B2 | Pet food compositions comprising caprylic acid and docosahexaenoic acid and/or eicosapetaenoic acid for use in treating struvite urolithiasis | HILL'S PET NUTRITION, INC. (US) | 2025-11-04 | — | — | US | disclosed |
| EP-3709817-B2 | COMPOSITIONS COMPRISING OMEGA-3 POLYUNSATURATED AND MEDIUM CHAIN FATTY ACIDS | HILLS PET NUTRITION INC (US) | 2025-10-22 | — | — | EP | disclosed |
| EP-4424365-A2 | PET FOOD COMPOSITIONS | Hill's Pet Nutrition, Inc. (US) | 2024-09-04 | — | — | EP | disclosed |
| US-20220394999-A1 | Pet Food Compositions | HILL'S PET NUTRITION, INC. (US) | 2022-12-15 | — | — | US | disclosed |
| EP-3709817-B1 | COMPOSITIONS COMPRISING OMEGA-3 POLYUNSATURATED AND MEDIUM CHAIN FATTY ACIDS | HILLS PET NUTRITION INC (US) | 2022-11-16 | — | — | EP | disclosed |
| US-20220202759-A1 | Pet Food Compositions Comprising Caprylic Acid and Docosahexaenoic Acid and/or Eicosapetaenoic Acid for Use in Treating Struvite Urolithiasis | HILL'S PET NUTRITION, INC. (US) | 2022-06-30 | — | — | US | disclosed |
| WO-2021127701-A1 | PET FOOD COMPOSITIONS | HILL'S PET NUTRITION, INC. (US) | 2021-06-24 | — | — | WO | disclosed |
| CN-106537145-B | Small molecule biochemical profiling of individual subjects for disease diagnosis and health assessment | 麦特博隆股份有限公司 | 2020-08-25 | — | — | CN | disclosed |
| EP-2230312-A1 | Probe compound for detecting and isolating enzymes and means and methods using the same | Helmholtz-Zentrum für Infektionsforschung GmbH (DE) | 2010-09-22 | — | — | EP | disclosed |
| EP-1052968-B1 | ALPHA-AMIDES OF(L)-AMINO ACIDS AS FRAGRANCE PRECURSORS | GILLETTE CO (US) | 2007-12-05 | — | — | EP | disclosed |
| EP-1052968-A4 | $g(a)-AMIDES OF $i(L)-AMINO ACIDS AS FRAGRANCE PRECURSORS | GILLETTE CO (US) | 2004-09-15 | — | — | EP | disclosed |
| EP-1052968-A1 | $g(a)-AMIDES OF $i(L)-AMINO ACIDS AS FRAGRANCE PRECURSORS | THE GILLETTE COMPANY (US) | 2000-11-22 | — | — | EP | disclosed |
| US-5932198-A | α-amides of L-amino acids as fragrance precursors | THE GILLETTE COMPANY (US) | 1999-08-03 | — | — | US | disclosed |
| WO-1999030680-A1 | α-AMIDES OF L-AMINO ACIDS AS FRAGRANCE PRECURSORS | THE GILLETTE COMPANY (US) | 1999-06-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260034086-A1 | Pet Food Compositions Comprising Caprylic Acid And Docosahexaenoic Acid And/Or Eicosapetaenoic Acid For Use In Treating Struvite Urolithiasis | FPR2, FPR1, FPR3 | ERAP2 122/4885P2RY14 183/4885ALOX15 184/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.